NCT05370820View on ClinicalTrials.gov

Prevention of Postpartum Hemorrhage With Tranexamic Acid

PHASE2RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 28, 2022

Primary Completion Date

May 2, 2026

Study Completion Date

October 30, 2026

Conditions
Post Partum Hemorrhage
Interventions
DRUG

Tranexamic acid

Tranexamic Acid 1000 mg administered intravenously via infusion over 10 minutes.

DRUG

Tranexamic acid

Tranexamic Acid 1000 mg administered intravenously via push over 2 minutes.

DRUG

Tranexamic acid

Tranexamic Acid 1000 mg administered intramuscularly.

OTHER

No intervention

Control group with no administration of Tranexamic Acid.

Trial Locations (2)

20037

RECRUITING

George Washington University Hospital, Washington D.C.

22042

RECRUITING

Inova Fairfax Medical Campus, Falls Church

Sponsors
All Listed Sponsors
collaborator

George Washington University

OTHER

collaborator

University of Maryland

OTHER

collaborator

University of North Carolina

OTHER

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Inova Health Care Services

OTHER